ENDRA Life Sciences Inc. NDRA
3.58 USD -0.13 (-3.38%)
Regular-session close
3.50 -0.08 -2.10%
After hours · Nov 20, 4:00 PM ET
3.42 Day range 3.73
2.96 52-week range 6.75
- YTD
- -21.08%
- 1 year
- -36.61%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -5.76M | -10.82M | -10.52M | -13.16M | -11.54M | |
| -7.03M | -11.51M | -10.06M | -13.18M | -11.23M | |
| -8.93 | -56.94 | -2,766.85 | -7,980.00 | -9,712.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 762.37K | 3.23M | 2.83M | 4.89M | 9.46M | |
| 3.85M | 4.45M | 6.75M | 9.27M | 12.87M | |
| 1.59M | 1.89M | 1.10M | 2.07M | 2.09M | |
| 492.35K | 584.42K | 394.40K | 546.63K | 678.96K | |
| 2.26M | 2.56M | 5.66M | 7.20M | 10.78M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -5.18M | -7.40M | -9.55M | -12.77M | -11.12M | |
| -3.02M | -12.80K | -24.72K | -202.58K | -45.00K | |
| 5.73M | 7.81M | 7.52M | 8.40M | 13.40M | |
| -17.28K | -12.80K | -24.72K | -202.58K | -45.00K | |
| -2.47M | 395.57K | -2.06M | -4.57M | 2.23M |
